Voloridge Investment Management, LLC Zymeworks Inc. Transaction History

Voloridge Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.43 $480,386 - $767,585	-103,309 Reduced 26.23%	290,610 $1.79 Million
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.7 $416,722 - $665,718	-86,457 Reduced 18.0%	393,919 $2.09 Million
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $2.09 Million - $5.91 Million	348,219 Added 263.49%	480,376 $3.15 Million
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $2.01 Million - $3.88 Million	132,157 New	132,157 $2.17 Million
Q2 2021 Aug 16, 2021	SELL	$26.5 - $38.23 $518,790 - $748,428	-19,577 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $417,023 - $794,203	13,980 Added 249.78%	19,577 $618,000
Q4 2020 Feb 16, 2021	BUY	$39.12 - $54.99 $218,954 - $307,779	5,597 New	5,597 $265,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $766M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.